Trafalgar International (GCAN) Receivables - Other (2019 - 2020)
Greater Cannabis Company (GCAN) posted quarterly Receivables - Other of $28000.0 for Q1 2020, little changed quarter-over-quarter from $28000.0 in Q4 2019.
Trafalgar International (GCAN) Receivables - Other (2019 - 2020) Analysis & Trends
Greater Cannabis Company's Receivables - Other history runs 2 years deep, the most recent figure standing at $28000.0 for Q1 2020.
- In Q1 2020, Receivables - Other changed N/A year-over-year to $28000.0; the TTM figure through Mar 2020 stood at $28000.0 (changed N/A YoY), while the FY2019 annual figure was $28000.0, changed N/A from the prior year.
- Receivables - Other for Q1 2020 stood at $28000.0, roughly flat from $28000.0 in the prior quarter.
- The five-year high for Receivables - Other was $28000.0 in Q4 2019, with the low at $28000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 28,000.00 |
| Mar 31, 2020 | 28,000.00 |
| Dec 31, 2019 | 28,000.00 |
| Dec 31, 2019 | 28,000.00 |